Mitigating Adverse Events in IVIG Therapy for CIDP is Key Role of Care Team
In an interview with Pharmacy TimesĀ®, Richard Lewis, MD, professor of neurology at Cedars-Sinai Medical Center in Los Angeles, highlights strategies to minimize the risks associated with intravenous immunoglobulin (IVIG) therapy in patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Lewis emphasizes that treatment providers must proactively identify and manage infusion-related side effects, such as allergic … Read more